Andrew Brown joins Cardiff Scintigraphics / i2c Pharmaceutical Services (CSL/i2c) as their new Chief Executive Officer

Andrew Brown joins Cardiff Scintigraphics / i2c Pharmaceutical Services (CSL/i2c) as their new Chief Executive Officer

Cardiff, UK, Press Release 30 May 2024

Cardiff Scintigraphics has appointed Andrew Brown as the new Chief Executive Officer and member of the Board of Directors, with effect from 03 June 2024. Andrew will be succeeding Glyn Taylor who will remain as a member of the Board and as Chief Scientific Officer in a part-time capacity.

Andrew is a proven leader and brings a wealth of experience over 20 years in senior pharmaceutical development, device development and operations in the pharmaceutical industry, with Sanofi-Aventis, GSK, Oriel and most recently, OBG Pharmaceuticals.

“I am honoured to lead such a talented team at CSL/i2c during this pivotal time. CSL/i2c’s unique offering and strong IP provide a great platform for future growth” said Andrew Brown.

“Andrew is clearly an inspiring person with the qualities and experience to lead CSL/i2c through the next phase of the company’s expansion and he has the unanimous support of the Board” said Glyn Taylor current CEO and a Founding Director of CSL/i2c.

Established in 1992, CSL/i2c is a leading contract research centre of excellence for inhaler development and testing, enabling the transitions from inception of concept and initial research findings through fast-tracking to clinical testing.


i2c are attending DDL 2023!

i2c will be attending DDL 2023 - Edinburgh International Conference Centre In Person, 6th - 9th December.

The Drug Delivery to the Lungs Conference (DDL) is in it’s 34th year and attracts in excess of 1000 attendees worldwide, including scientists, academics, clinicians, regulators and industry experts.

The conference includes a large industry exhibition, supported by over 100 international companies, a scientific poster hall, expert lectures and excellent networking opportunities over the 3-day event.

DDL actively supports young scientists by offering free registration for students, Career Development Grants and a variety of awards, recognising their achievements.

Find Out More

i2c are attending DDL 2022!

i2c will be attending DDL 2022 - Edinburgh International Conference Centre In Person, 7th/8th/9th December.

DDL attracts a wide variety of attendees, including scientists, academics, clinicians, regulators and industry experts.

DDL offers the opportunity for lectures, posters and exhibitions to be closely located thereby enhancing interactions and networking opportunities for attendees, presenters and exhibitors.

DDL is a not-for-profit conference and any surplus funds are provided as grants or awards, targeting research and training of the next generation of aerosol and drug delivery scientists.

Find Out More